跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MEDRINATE SYRUP 25 mg/5 ml - HSA Drug Approval Details
Approvals
/
HSA
/
MEDRINATE SYRUP 25 mg/5 ml
Approved
THERAPEUTIC
MEDRINATE SYRUP 25 mg/5 ml
HOVID BHD
🇸🇬 Health Sciences Authority
Approval Date
Jan 10, 1994
Approval ID
6df039f03f03f3b3
Company
HOVID BHD
Type
Therapeutic
Approval Details
Approval Id
6df039f03f03f3b3
Drug Name
MEDRINATE SYRUP 25 mg/5 ml
Product Name
MEDRINATE SYRUP 25 mg/5 ml
Approval Number
SIN07645P
Approval Date
1994-01-10
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
Pharmacy Only
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
A04AD
Atc Item Name
其它镇吐药
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
DIMENHYDRINATE
25 mg/5 ml
DIMENHYDRINATE
25 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 10, 1994
Approval ID
6df039f03f03f3b3
Type
Therapeutic
Back to HSA Approvals